Advertisement
Advertisement
Trending on Urology Times
1
Interpreting real-world evidence in ARPI treatment decisions, with Martin Schoen, MD, PhD
2
John Sfakianos, MD, discusses evolving management of recurrent LG-IR-NMIBC
3
Phase 3 trial of padeliporfin VTP completes treatment in LG-UTUC
4
Dabogratinib shows early activity in FGFR3-altered LG-IR-NMIBC
5